News

Wells Fargo Raises JPMorgan (JPM) Price Target, Cites Market Leadership and Strong Capital
JPMorgan Chase & Co. (NYSE:JPM) is one of the 15 best stocks to invest in for an 18 year old. Analysts at Wells Fargo raised ...
Investing Snacks18h
Regeneron’s Stock Gets a Shot in the Wallet
Regeneron Pharmaceuticals took a modest hit as BDF Gestion reduced its stake by 11.5% in the first quarter, now holding $2.8 ...
Kratos Set For Lift-Off Despite Early Turbulence: JPMorgan Spotlights Mid-Cap Defense Firms
J.P. Morgan sees mid-cap defense firms like Kratos rebounding in the second half of 2025 amid Pentagon-driven tailwinds.
Investing Snacks1d
Regeneron Gets a Dose of Pallas Capital
Pallas Capital Advisors jumped into the biotech game by purchasing $426,000 worth of Regeneron Pharmaceuticals shares during ...
Wells Fargo Sticks to Its Hold Rating for Pfizer (PFE)
Wells Fargo analyst Mohit Bansal maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $28.00. The company’s shares closed yesterday a ...
JPMorgan Calls the Selloff Excessive, Trims Regeneron Pharmaceuticals, Inc. (REGN) Price Target
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has maintained its Overweight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ...